Back

Efficacy and safety of switching simvastatin intolerant patients with coronary artery disease to rosuvastatin treatment

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Treatment of dyslipidaemia Drug therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Aleksandr Shek

Specialized Cardiology Center of the Republic of Uzbekistan, Tashkent (Uzbekistan)

3 More presentations in this session

Presentation thumbnail
Treatment and control of dyslipidemia among adults in northeastern China: results of the dyslipidemia international study (DYSIS)
Doctor W. Zheng (Beijing, CN)
Abstract Slides
Presentation thumbnail
Anti-proprotein convertase subtilisin-kexin type 9 monoclonal antibodies: effects on lipid profile and arterial stiffness
Presentation thumbnail
Evaluation of statin users, people with hypercholesterolemia, and cardiovascular disease patients in the Japan Medical Data Center claims database
Doctor K. Monda (Thousand Oaks, US)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - Treatment of dyslipidaemia

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources